CytomX Therapeutics, Inc.

1. 01

   Behind SPY and its sector fund XLV over 1 year

   1 month: −8.2% (SPY −1.6%, XLV +13.5%). 3 months: −29.9% (SPY −0.4%, XLV +15.5%). 1 year: −42.5% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: CTMX, SPY and XLV · as of 4 Nov 2026

2. 02

   9.8% above its 52-week low

   Closed at $2.35 on 4 Nov 2026: 66.3% below the 52-week high of $6.97 (16 Mar 2026) and 9.8% above the low of $2.14 (2 Nov 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

3. 03

   13.8 days to cover short interest

   42.8M shares were sold short at the 15 Oct 2026 settlement, 19.6% of the 217.9M shares outstanding; covering them would take 13.8 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

4. 04

   Below its 50- and 200-day averages

   The 4 Nov 2026 close of $2.35 was 14.9% below its 50-day average ($2.76) and 38.7% below its 200-day average ($3.83). It has closed below the 200-day for 124 sessions, since 11 May 2026. The 50-day average crossed below the 200-day on 10 Jun 2026, 102 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

5. 05

   Volume 1.8× its 30-session average on 4 Nov 2026

   4 Nov 2026 volume of 6.6M shares was 1.8× the average of the 30 sessions before it (3.7M), as the price rose 7.8%. SPY traded 1.5× its own average that session.

   Daily volume against a 30-session baseline · as of 4 Nov 2026

At the 4 Nov 2026 close